share_log

Cyclacel Pharmaceuticals Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Acorn Bioventures, L.P.(0%),Acorn Capital Advisors GP, LLC(0%), etc.

Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G/A:超過5%持股股東披露文件(修正)-Acorn Bioventures, L.P.(0%),Acorn Capital Advisors GP, LLC(0%)等

美股SEC公告 ·  02/07 17:08
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息